Nom du produit:Ethyl 2-{7-hydroxy-1H,2H,3H,4H-cyclopenta[b]indol-3-yl}acetate

IUPAC Name:ethyl 2-{7-hydroxy-1H,2H,3H,4H-cyclopenta[b]indol-3-yl}acetate

CAS:1206124-13-1
Formule moléculaire:C15H17NO3
Pureté:95%+
Numéro de catalogue:CM333532
Poids moléculaire:259.31

Unité d'emballage Stock disponible Prix($) Quantité
CM333532-100mg in stock ľǙǙ
CM333532-250mg in stock ȃǪľ
CM333532-1g 3-4 Weeks ǙIJIJŹ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1206124-13-1
Formule moléculaire:C15H17NO3
Point de fusion:-
Code SMILES:O=C(OCC)CC1CCC2=C1NC3=C2C=C(O)C=C3
Densité:
Numéro de catalogue:CM333532
Poids moléculaire:259.31
Point d'ébullition:
N° Mdl:
Stockage:

Column Infos

Indoles
Indole is a compound of pyrrole and benzene in parallel, also known as benzopyrrole. There are two combinations of pyrrole and benzene, called indole and isoindole, respectively. Many derivatives of indole have physiological and pharmacological activities, and can synthesize vasodilators, antihistamines, antipyretic analgesics, etc. in medicine, so indole is also a very important heterocyclic compound.
Etrasimod
Etrasimod is a new generation of oral S1P receptor modulator, which can specifically bind to S1P receptors 1, 4, and 5. It is being studied for a range of immune inflammatory diseases, including ulcerative colitis, Crohn's disease, atopic dermatitis, eosinophilic esophagitis and alopecia areata. At present, the highest stage of research and development of the drug is to apply for marketing, which is used to treat ulcerative colitis and is expected to be approved by FDA in this month.

Related Products